PCM
ABMD

Penserra Capital Management’s Abiomed Inc ABMD Stock Holding History

Penserra Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,191
Closed -$1.23M – 958
2019
Q4 		$1.23M Buy
+7,191
New +$1.33M 0.08% 268
2019
Q1 		– Sell
-21,149
Closed -$6.87M – 819
2018
Q4 		$6.87M Sell
21,149
-29,405
-58% -$10.2M 0.67% 57
2018
Q3 		$22.7M Buy
50,554
+13,745
+37% +$5.42M 1.4% 13
2018
Q2 		$15.1M Sell
36,809
-6,022
-14% -$2.18M 0.95% 37
2018
Q1 		$12.5M Buy
+42,831
New +$10.9M 1.18% 21
2016
Q4 		– Sell
-2,817
Closed -$362K – 977
2016
Q3 		$362K Buy
+2,817
New +$337K 0.04% 113

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Penserra Capital Management's ABMD Position: Q1 2020 in Review

Penserra Capital Management sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 7,191 shares — an estimated $1.23M sold.

Penserra Capital Management first reported a position in ABMD in Q3 2016 and held it in 6 quarters. The position peaked at $22.7M in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Penserra Capital Management reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Penserra Capital Management sold 7,191 Abiomed Inc shares in Q1 2020, an estimated $1.23M.
  • Penserra Capital Management first reported a position in Abiomed Inc in Q3 2016 and held it in 6 quarters.
  • Penserra Capital Management's Abiomed Inc position peaked at $22.7M in Q3 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Penserra Capital Management's 13F filing for Q1 2020, filed 14 May 2020.